Tonabersat

DB06578InvestigationalSmall molecule

Investigated for use/treatment in migraine and cluster headaches.

Chemical structure of Tonabersat
Primary indication
Investigated for use/treatment in migraine and cluster headaches.Curator reviewed
Formula / weight
C20H19ClFNO4 · 391.82 g/mol (avg)
Code names
SB-220453

Resolves to

Compound
UNII2XD9773ZMNCAS175013-84-0ChEMBLCHEMBL318191
Structure
InChIKeyXLIIRNOPGJTBJD-ROUUACIJSA-NSMILESCC(=O)C1=CC=C2OC(C)(C)[C@@H](O)[C@@H](NC(=O)C3=CC=C(F)C(Cl)=C3)C2=C1
Targets
P28221HTR1D

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Tonabersat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In